A vaccine for intradermal application against pcv2 and prrs virus infection
AssigneeIntervet Inc.
InventorsMelanie Sno, Maarten Hendrik Witvliet, Vicky Fachinger
Life of this patent
Estimating the term…
Abstract
The present invention pertains to a vaccine comprising in combination non-replicating immunogen of porcine circo virus type 2 and live attenuated PRRS virus for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with PRRS virus by administration of the vaccine into the dermis of the animal.
Claims20
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A vaccine comprising in combination a non-replicating immunogen of porcine circovirus type 2 (PCV2) and a live attenuated porcine reproductive and respiratory syndrome (PRRS) virus for use in prophylactically treating an animal against an infection of PCV2, PRRS virus, or both PCV2 and PRRS virus, wherein the vaccine is administered into the dermis of the animal.
A method for prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2), an infection with porcine reproductive and respiratory syndrome (PRRS) virus, or an infection with both PCV2 and PRRS virus, by administrating into the dermis of the animal a vaccine comprising in combination non-replicating immunogen of PCV2 and live attenuated PRRS virus.
A method of manufacturing a vaccine comprising the non-replicating immunogen of porcine circovirus type 2 (PCV2) and live attenuated porcine reproductive and respiratory syndrome (PRRS) virus for intradermal administration to an animal to prophylactically treat the animal against an infection with PCV2, an infection with PRRS virus, or an infection of both PCV2 and PRRS virus.
Dependencies are inferred from the claim text.